title: Re: Botulinum neurotoxin A: an unusual systemic effect 43 (2007) 499-501.
authors.forename: Adam
authors.initials: A
authors.lastname: Scheinberg
authors.forename: Stephen
authors.initials: S
authors.lastname: O'Flaherty
authors.forename: Mary-Clare
authors.initials: MC
authors.lastname: Waugh
authors.forename: Alexandra
authors.initials: A
authors.lastname: Baxter
authors.forename: Kristy
authors.initials: K
authors.lastname: Gurd
mesh_terms: D000293:Adolescent; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002547:Cerebral Palsy / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011446:Prospective Studies
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A